Literature DB >> 29094391

Investigating the assumptions of the self-controlled case series method.

Heather J Whitaker1,2, Yonas Ghebremichael-Weldeselassie1,3, Ian J Douglas2, Liam Smeeth2, C Paddy Farrington1.   

Abstract

We describe some simple techniques for investigating 2 key assumptions of the self-controlled case series (SCCS) method, namely, that events do not influence subsequent exposures and that events do not influence the length of observation periods. For each assumption, we propose some simple tests based on the standard SCCS model, along with associated graphical displays. The methods also enable the user to investigate the robustness of the results obtained using the standard SCCS model to failure of assumptions. The proposed methods are investigated by simulations and applied to data on measles, mumps and rubella vaccine, and antipsychotics.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  assumptions; event dependent exposures; event dependent observation period; self controlled case series

Mesh:

Substances:

Year:  2017        PMID: 29094391     DOI: 10.1002/sim.7536

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  11 in total

1.  Comparison of Self-controlled Designs for Evaluating Outcomes of Drug-Drug Interactions: Simulation Study.

Authors:  Katsiaryna Bykov; Jessica M Franklin; Hu Li; Joshua J Gagne
Journal:  Epidemiology       Date:  2019-11       Impact factor: 4.822

2.  The Case Time Series Design.

Authors:  Antonio Gasparrini
Journal:  Epidemiology       Date:  2021-11-01       Impact factor: 4.822

3.  Effect of herpes zoster vaccine and antiviral treatment on risk of ischemic stroke.

Authors:  Quanhe Yang; Mary G George; Anping Chang; Xin Tong; Robert Merritt; Yuling Hong
Journal:  Neurology       Date:  2020-07-07       Impact factor: 9.910

4.  Drug-Drug Interaction Surveillance Study: Comparing Self-Controlled Designs in Five Empirical Examples in Real-World Data.

Authors:  Katsiaryna Bykov; Hu Li; Sangmi Kim; Seanna M Vine; Vincent Lo Re; Joshua J Gagne
Journal:  Clin Pharmacol Ther       Date:  2020-12-17       Impact factor: 6.875

5.  Antibiotic treatment and flares of rheumatoid arthritis: a self-controlled case series study analysis using CPRD GOLD.

Authors:  Navraj S Nagra; Danielle E Robinson; Ian Douglas; Antonella Delmestri; Stephanie G Dakin; Sarah J B Snelling; Andrew J Carr; Daniel Prieto-Alhambra
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

6.  Assessment of risk of intussusception after pilot rollout of rotavirus vaccine in the Indian public health system.

Authors: 
Journal:  Vaccine       Date:  2020-06-16       Impact factor: 3.641

7.  Association between rotavirus gastroenteritis and intussusception: suggested evidence from a retrospective study in claims databases in the United States.

Authors:  Corinne Willame; Brigitte Cheuvart; Emmanuel Aris; Volker Vetter; Catherine Cohet
Journal:  Hum Vaccin Immunother       Date:  2020-07-01       Impact factor: 3.452

8.  Respiratory tract infection and risk of bleeding in oral anticoagulant users: self-controlled case series.

Authors:  Haroon Ahmed; Heather Whitaker; Daniel Farewell; Julia Hippisley-Cox; Simon Noble
Journal:  BMJ       Date:  2021-12-21

9.  Serious complications and risk of re-operation after Dupuytren's disease surgery: a population-based cohort study of 121,488 patients in England.

Authors:  Osaid Alser; Richard S Craig; Jennifer C E Lane; Albert Prats-Uribe; Danielle E Robinson; Jonathan L Rees; Daniel Prieto-Alhambra; Dominic Furniss
Journal:  Sci Rep       Date:  2020-10-05       Impact factor: 4.379

10.  Bariatric surgery increases the rate of major fracture: self-controlled case series study in UK Clinical Practice Research Datalink.

Authors:  Danielle E Robinson; Ian Douglas; Garry D Tan; Antonella Delmestri; Andrew Judge; Cyrus Cooper; M Kassim Javaid; Victoria Y Strauss; Daniel Prieto-Alhambra
Journal:  J Bone Miner Res       Date:  2021-07-29       Impact factor: 6.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.